Evidence map›Paper›PMID 33121062›Full record

GuidelineNutrients2020

Nutritional Guideline for the Management of Mexican Patients with CKD and Hyperphosphatemia.

Frida Palafox-Serdán, Olinto A Luna-Montiel, Sebastián E Pablo-Franco, Daniela L Guillen-Tejada, Sandra D Carreño-Vázquez, Taísa S Silva Pereira, Laura M Islas Romero, Karen Villaseñor López, Ana E Ortega-Régules, Aura M Jiménez-Garduño

Open access · goldAbstract readPractice Guideline
In one paragraph

Guideline in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Frida Palafox-SerdánHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.
Olinto A Luna-MontielHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.
Sebastián E Pablo-FrancoHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.
Daniela L Guillen-TejadaHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.
Sandra D Carreño-VázquezHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.
Taísa S Silva PereiraHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.ORCID 0000-0002-5922-7424
Laura M Islas RomeroHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.
Karen Villaseñor LópezHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.
Ana E Ortega-RégulesHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.
Aura M Jiménez-GarduñoHealth Sciences Department, Universidad de las Américas Puebla, UDLAP, Ex Hacienda Sta. Catarina Mártir S/N. Puebla, C.P. San Andrés Cholula 72810, Mexico.
Universidad de las Américas Puebla · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) represents a serious concern for the Mexican population since the main predisposing diseases (diabetes, hypertension, etc.) have a high prevalence in the country. The development of frequent comorbidities during CKD such as anemia, metabolic disorders, and hyperphosphatemia increases the costs, symptoms, and death risks of the patients. Hyperphosphatemia is likely the only CKD comorbidity in which pharmaceutical options are restricted to phosphate binders and where nutritional management seems to play an important role for the improvement of biochemical and clinical parameters. Nutritional interventions aiming to control serum phosphate levels need to be based on food tables, which should be specifically elaborated for the cultural context of each population. Until now, there are no available food charts compiling a high amount of Mexican foods and describing phosphorus content as well as the phosphate to protein ratio for nutritional management of hyperphosphatemia in CKD. In this work, we elaborate a highly complete food chart as a reference for Mexican clinicians and include charts of additives and drug phosphate contents to consider extra sources of inorganic phosphate intake. We aim to provide an easy guideline to contribute to the implementation of more nutritional interventions focusing on this population in the country.

Indexed as

Nutrition PolicyDietFood AdditivesHumansHyperphosphatemiaMexicoPhosphorus, DietaryRenal Insufficiency, ChronicFood AdditivesPhosphorus, Dietarychronic kidney diseasehyperphosphatemiaMexican food chartnutritional management

Identifiers

PMID33121062
PMCPMC7693767
OpenAlexW3094687233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.